GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
C/NL/06/01_001 Suntory Flowers Limited Application for renewal of consent for marketing approval under Directive 2001/18/EC (Event FLORIGENE®Moonaqua™(FLO-4Ø689-6)) 09-11-2018 Vergunning verleend
IM-MV 18-004_000 Universitair Medisch Centrum Utrecht Phase I/II multicenter clinical trial of VXM01 in combination with avelumab in patients with progressive glioblastoma and further clinical studies with VXM01 in patients with solid malignancies. 15-03-2019 Vergunning verleend
IM-MV 18-005_000 Universitair Medisch Centrum Utrecht Clinical development program for a gene replacement therapy for patients with Spinal Muscular Atrophy utilizing AVXS-101, an adeno-associated viral vector serotype 2/9 containing the human SMN gene. Ontwerpbesluit genomen
IM-MV 19-003_000 Erasmus MC An open-label, Phase I/II multicenter clinical trial of VXM01 in combination with avelumab in patients with progressive glioblastoma and further clinical studies with VXM01 in patients with solid malignancies Ontwerpbesluit genomen